☰

rating

Ryan Morin committed 2024-06-18 08:37:55 -0700 commit 4ed53cff0515950274d0769bbd7a736e57a2769a

				papers/hubschmannMutationalMechanismsShaping2021b.md
			
          @@ -44,9 +44,9 @@ All other DLBCL studies, DLBCL Tier 2, 175

           ### Tier 2

           |New gene|FL tier|DLBCL tier|Average variant quality|QC outcome|

           |:-|:-:|:-:|:-:|:-:|

          -|[ADAMTS1](../ADAMTS1)| |2 |&starf; &starf; &starf; &star; &star; | **Pass** |

          -|[ANKRD12](../ANKRD12)| |2 |&starf; &starf; &starf; &star; &star; | **Pass** |

          -|[ATP6V1A](../ATP6V1A)|2 | |||

          +|[ADAMTS1](../ADAMTS1)| |2 |&starf; &starf; &starf; &star; &star; | *Pass* |

          +|[ANKRD12](../ANKRD12)| |2 |&starf; &starf; &starf; &star; &star; | *Pass* |

          +|[ATP6V1A](../ATP6V1A)|2 | |&starf; &starf; &starf; &starf; &star; | *Pass* |

           |[CADPS2](../CADPS2)| |2 |||

           |[CCDC42BPB](../CCDC42BPB)|2 | |||

           |[CNOT2](../CNOT2)| |2 |||

...	...	@@ -44,9 +44,9 @@ All other DLBCL studies, DLBCL Tier 2, 175
44	44	### Tier 2
45	45	\|New gene\|FL tier\|DLBCL tier\|Average variant quality\|QC outcome\|
46	46	\|:-\|:-:\|:-:\|:-:\|:-:\|
47		-\|[ADAMTS1](../ADAMTS1)\| \|2 \|&starf; &starf; &starf; &star; &star; \| Pass \|
48		-\|[ANKRD12](../ANKRD12)\| \|2 \|&starf; &starf; &starf; &star; &star; \| Pass \|
49		-\|[ATP6V1A](../ATP6V1A)\|2 \| \|\|\|
	47	+\|[ADAMTS1](../ADAMTS1)\| \|2 \|&starf; &starf; &starf; &star; &star; \| Pass \|
	48	+\|[ANKRD12](../ANKRD12)\| \|2 \|&starf; &starf; &starf; &star; &star; \| Pass \|
	49	+\|[ATP6V1A](../ATP6V1A)\|2 \| \|&starf; &starf; &starf; &starf; &star; \| Pass \|
50	50	\|[CADPS2](../CADPS2)\| \|2 \|\|\|
51	51	\|[CCDC42BPB](../CCDC42BPB)\|2 \| \|\|\|
52	52	\|[CNOT2](../CNOT2)\| \|2 \|\|\|